The authors present a study in which they sought to identify patterns of disparities in race and sex in the use of health care resources by Medicaid patients with COPD, a population composed predominantly of minorities, women, and children.
You are here
P&T® Journal contents for May 2006
Utilization of Health Care Resources in a High-Risk Medicaid Population with Chronic Obstructive Pulmonary Disease
Topics include therapies with atorvastatin for hypercholesterolemia and mixed dyslipidemia, aliskiren and darusentan for hypertension, perindopril for coronary artery disease, bivalirudin for acute coronary syndrome, atorvastatin for atrial fibrillation, and darbepoetin alfa and carvedilol for heart failure.
Dr. Goldenberg reviews advances in the treatment of lymphoma, including chemotherapeutic agents, monoclonal antibodies, radiolabeled products, and antisense drugs.
Continuing Education Credit
National Guidelines for a Novel Therapy: Update on Clinical Trials and Experience Using Consensus Panel Recommendations for Incorporating Omalizumab into Asthma Management
A panel of experts in allergies and pulmonology discuss the appropriate use of omalizumab with respect to current asthma guidelines and review the drug’s ability to improve symptoms, reduce exacerbations, and decrease patients’ use of health care resources.